Chairman and Chief Executive Officer
Philippe Archinard became Chief Executive Officer (CEO) in December 2004 and Chairman in June 2010. Prior to joining Transgene, he served as CEO of Innogenetics, beginning in 2000. He began his professional career with bioMérieux in 1985, where he held various positions in France and the United States, including CEO of U.S. operations. Since 2014, Philippe Archinard is Chairman of the Bioaster Scientific Cooperation Foundation, an Institute of Technological Research dedicated to infectiology and microbiology. He holds a chemical engineering degree and a PhD in biochemistry from Lyon University and has completed the Program for Management Development (PMD) at Harvard Business School.